Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $31.37 Analyst target: $54.02 Upside: 72.20%
Nanobiotix SA, a clinical-stage biotechnology, is focused on the development of candidate products for the treatment of cancer. The company is headquartered in Paris, France.
See the full interactive analysis & chart →Informational only — not investment advice.